Capstone Investment Advisors’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$3.59M Buy
10,200
+2,900
+40% +$1.03M 0.01% 497
2025
Q4
$2.39M Sell
7,300
-8,100
-53% -$2.57M ﹤0.01% 563
2025
Q3
$4.35M Buy
15,400
+800
+5% +$232K 0.01% 508
2025
Q2
$4.08M Sell
14,600
-4,200
-22% -$1.19M 0.01% 431
2025
Q1
$5.86M Sell
18,800
-17,600
-48% -$5.2M 0.02% 412
2024
Q4
$9.49M Buy
36,400
+11,300
+45% +$3.35M 0.02% 369
2024
Q3
$8.09M Buy
25,100
+2,700
+12% +$883K 0.02% 347
2024
Q2
$7M Buy
22,400
+7,200
+47% +$2.12M 0.02% 373
2024
Q1
$4.32M Sell
15,200
-9,100
-37% -$2.66M 0.02% 493
2023
Q4
$7M Buy
24,300
+13,200
+119% +$3.6M 0.02% 426
2023
Q3
$2.98M Buy
11,100
+5,000
+82% +$1.25M 0.01% 585
2023
Q2
$1.35M Buy
6,100
+2,200
+56% +$510K 0.01% 759
2023
Q1
$943K Sell
3,900
-7,800
-67% -$1.91M ﹤0.01% 815
2022
Q4
$3.07M Sell
11,700
-900
-7% -$241K 0.02% 554
2022
Q3
$2.84M Sell
12,600
-2,300
-15% -$558K 0.02% 607
2022
Q2
$3.63M Sell
14,900
-35,800
-71% -$8.77M 0.02% 515
2022
Q1
$12.3M Sell
50,700
-34,300
-40% -$7.88M 0.03% 397
2021
Q4
$19.1M Buy
85,000
+3,000
+4% +$633K 0.03% 438
2021
Q3
$17.4M Sell
82,000
-8,000
-9% -$1.84M 0.03% 457
2021
Q2
$21.9M Sell
90,000
-3,000
-3% -$738K 0.05% 334
2021
Q1
$23.1M Buy
93,000
+17,500
+23% +$4.18M 0.07% 267
2020
Q4
$17.4M Buy
75,500
+9,900
+15% +$2.28M 0.06% 273
2020
Q3
$16.7M Buy
65,600
+25,300
+63% +$6.27M 0.09% 207
2020
Q2
$9.51M Buy
40,300
+35,500
+740% +$8.1M 0.06% 269
2020
Q1
$973K Sell
4,800
-48,200
-91% -$10.5M 0.02% 718
2019
Q4
$12.8M Sell
53,000
-4,400
-8% -$970K 0.07% 292
2019
Q3
$11.1M Buy
57,400
+15,800
+38% +$3.03M 0.08% 263
2019
Q2
$7.67M Sell
41,600
-4,500
-10% -$806K 0.06% 356
2019
Q1
$8.76M Buy
46,100
+23,900
+108% +$4.56M 0.08% 237
2018
Q4
$4.32M Buy
22,200
+1,500
+7% +$293K 0.05% 275
2018
Q3
$4.29M Buy
20,700
+18,300
+763% +$3.61M 0.05% 279
2018
Q2
$443K Buy
+2,400
New +$425K 0.01% 493
2017
Q2
Sell
-200
Closed -$32K 625
2017
Q1
$32K Sell
200
-4,700
-96% -$781K ﹤0.01% 829
2016
Q4
$714K Buy
+4,900
New +$737K 0.02% 501
2014
Q1
Sell
-121,600
Closed -$13.9M 374
2013
Q4
$13.9M Sell
121,600
-29,400
-19% -$3.34M 0.15% 76
2013
Q3
$16.9M Buy
151,000
+44,400
+42% +$4.81M 0.17% 70
2013
Q2
$10.5M Buy
+106,600
New +$11.1M 0.11% 90

Other funds holding AMGN

Capstone Investment Advisors's AMGN Position: Q1 2026 in Review

Capstone Investment Advisors opened a new position in Amgen (AMGN) in Q1 2026: 1,702 shares worth $599K. The stake represents ﹤0.01% of the portfolio and ranks #1068 among its holdings. This is a return to the name: Capstone Investment Advisors previously reported a position in AMGN as recently as Q3 2025.

Capstone Investment Advisors first reported a position in AMGN in Q3 2013 and has held it in 30 quarters since. The position peaked at $29.7M in Q3 2021. 3,131 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

  • Capstone Investment Advisors held 1,702 shares of Amgen worth $599K as of Q1 2026.
  • Amgen was a new Capstone Investment Advisors position in Q1 2026.
  • Amgen made up ﹤0.01% of Capstone Investment Advisors's portfolio in Q1 2026, its #1068 holding.
  • Capstone Investment Advisors first reported a position in Amgen in Q3 2013 and has held it in 30 quarters since.
  • Capstone Investment Advisors's Amgen position peaked at $29.7M in Q3 2021.
  • 3,131 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on Capstone Investment Advisors's 13F filing for Q1 2026, filed 15 May 2026.